Roth Capital initiates coverage on NeoStem (NYSE Amex: NBS) with a Buy rating. Price target $2.50 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE